Scholars Central

Research articlePublished 2018

Variation of Serum Transaminases in HIV/AIDS Patients on Different Antiretroviral Regimens, Attending the Saint Elizabeth Hospital, Shisong, Northwest Region, Cameroon

Authors: Akomoneh Elvis Achondou, Roger Atanga, Elizabeth J Tanlaka, Ajonina Marcelus Utokoro, Foche Francis Fumoloh

Tropical Medicine & Surgery

Volume 6 · Issue 1 · Pages 1–5

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Antiretroviral drugs help reduce the viral load in HIV patients and prevent further progression of the virus. Hepatotoxicity has been reported among HIV patients receiving Highly Active Antiretroviral Therapy (HAART). There is therefore the need to monitor liver enzyme activity in HIV seropositive patients on different antiretroviral (ARV) regimens. This study thus aimed at determining the variation of serum transaminases; aspartate aminotransferase (AST) and alanine aminotransferase (ALT) amongst HIV/AIDS patients on different ARV regimens at the Saint Elizabeth Hospital, Shisong with respect to different ARV regimens, age groups, gender, and duration on ARV therapy. The results will guide health personnel in administering anti-retroviral therapy to HIV/AIDS patients and bring to focus the need for a liver function test before placing a patient on antiretroviral therapy. In this crosssectional exploratory hospital and laboratory-based study involving 57 participants, venous blood was collected and the absorbance and concentration of serum transaminases for each subject read using a spectrophotometer. Data obtained were analyzed using SPSS and the Chi-Square test used to determine association and significance at Pvalue ≤ 0.05. Results showed there was significant elevation of transaminases among study participants. Elevation of transaminases was more pronounced for AST (47.4%) than ALT (19.3%). Regarding the different ARV regimens, participants on a combination of Nucleoside Reverse Transcriptase Inhibitor and Non-Nucleoside Reverse Transcriptase Inhibitor (NRTI+NNRTI) had higher transaminase elevations than those who were on single or triple combinations. With respect to sex, elevation of AST levels was significantly higher (RR=1.0962) in females (48.7%) than males (44.4%). For ALT, males tend to have more elevated levels than females but the difference was not significant (RR=0.8077). There was no significant difference in transaminase levels with age groups (P>0.05).

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

More from this journal

The newest in Tropical Medicine & Surgery.

All its articles

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalTropical Medicine & Surgery
  • SubjectSurgery
  • SubjectInfectious Diseases
  • BylineArticles whose byline prints “Akomoneh Elvis Achondou”
  • BylineArticles whose byline prints “Roger Atanga”
  • BylineArticles whose byline prints “Elizabeth J Tanlaka”
  • BylineArticles whose byline prints “Ajonina Marcelus Utokoro”
  • BylineArticles whose byline prints “Foche Francis Fumoloh”